MR-based performance tests for overweight and obesity
Official title: Validity and Reliability of the Mixed Reality Adaptation of Performance Tests in Overweight and Obese Individuals
Run by Selcuk University · NCT07654439 · Data updated 2026-11-12
This study tests mixed reality versions of mobility tests to see if they match conventional assessments in adults who are overweight or obese.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 119 (estimated) |
| Sponsor | Selcuk University Academic / other |
| Locations | 1 site (Konya, Selcuklu) |
| Status | Recruiting |
| Started | June 10, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | May 10, 2027 |
| Registry record updated | June 17, 2026 |
| Trial ID | NCT07654439 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with BMI ≥ 25 kg/m² who can ambulate independently and consent to participate.
✕Probably not a fit
Individuals who cannot safely perform mobility tests or have conditions that preclude MR testing may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares mixed reality–based adaptations of functional mobility tests, developed on the Meta Quest 3 platform, with standard clinical measures. It aims to determine the validity and reliability of MR-based assessments for overweight and obese adults. Participants will perform both MR and traditional tests such as the 6-minute walk and Timed Up and Go, with data collected automatically in MR environments. The study will explore how visual and vestibular aspects of MR impact performance and how well MR outcomes align with conventional measures. Lead by Selcuk University in Konya, the project seeks standardized, interactive assessment options for mobility in this population.
Why it matters
Potential benefit: If successful, MR-based tests could offer standardized, interactive assessments with automated data capture to support clinical decision-making.
How similar studies have gone: Virtual and mixed reality mobility assessments have shown good reliability and associations with traditional measures in prior research, though MR validation is still being established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Body Mass Index (BMI) ≥ 25 kg/m² (overweight or obesity), * Ability to ambulate independently, * Aged between 18 and 65 years, * Willingness to participate voluntarily in the study and provide written informed consent. Exclusion Criteria: * Use of anti-obesity medication, * Pregnancy, * Latent autoimmune diabetes in adults (LADA), * Chronic kidney disease, * Active or severe infections, * Liver failure, * Recent major cardiovascular events, * Unstable angina, * Heart failure classified as New York Heart Association (NYHA) Class III-IV, * Respiratory failure, cardiac arrhythmias, neoplastic diseases, or neurological or musculoskeletal disorders that may limit the safe performance of the tests.
Where it's running
-
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Konya, Selcuklu, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Mehmet K ALTUNOK, PHD(c) in PT
- Email: mehmetkaan.altunok@selcuk.edu.tr
- Phone: 5558175133
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nutrition support to improve dietary diversity in adults who are underweight or overweight/obese
A community-based nutrition program will be tested in adults in Cambodia to see if it improves dietary diversity and if the program is acceptable and feasible to run.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
DA-302168S in adults with overweight or obesity
A phase 3 trial in China is testing whether DA-302168S helps people who are overweight or obese lose weight compared with a placebo.
-
Metabolic Health Trajectories in Overweight Chinese Adults
This observational study follows overweight and obese Chinese adults to see how metabolic health changes over five years and whether people stay healthy, develop diabetes, or have complications.
-
Blood-count inflammation scores (SII and SIRI) to predict metabolic complications in adults with overweight or obesity
This project will test whether two blood-count-based scores (SII and SIRI) can help predict metabolic complications and treatment response in adults with overweight or obesity.
-
4-week nightly ketogenic supplement to improve nighttime metabolism and muscle health
We will test whether taking a ketogenic nutritional supplement each evening for 4 weeks helps older adults who are overweight improve their daily energy metabolism patterns and muscle health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.